Small Animal Imaging Market Size, Share & Trends Analysis Report By Technology (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Single Photon Emission Computed Tomography (SPECT), Optical Imaging, Photoacoustic Imaging, Others), By Applications (Drug Discovery and Disease Modeling, Preclinical Drug Development, Clinical Trials, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organization) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Small Animal Imaging Market Size

The global small animal imaging market size was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.33 billion in 2026 to USD 2.24 billion by 2034, registering a CAGR of 6.7% during the forecast period from 2026 to 2034. North America dominated the small animal imaging market with a market share of 39.2% in 2025.

Small animal imaging refers to the non-invasive visualization and analysis of biological processes in small laboratory animals, such as mice and rats, which are widely utilized in preclinical research. This technique employs advanced imaging modalities, including positron emission tomography (PET), magnetic resonance imaging (MRI), computed tomography (CT), optical imaging, and ultrasound, to study disease progression, monitor treatment efficacy, and support drug development.

By providing high-resolution anatomical, functional, and molecular insights, small animal imaging enables researchers to investigate complex biological systems in vivo, significantly reducing the need for invasive procedures. It serves as a critical tool in translational research, bridging laboratory discoveries and clinical applications while accelerating drug discovery and development processes.

The global market is experiencing rapid growth, driven by advancements in imaging technologies such as high-field systems and multimodal imaging. These innovations enable more detailed studies on disease progression, drug efficacy, and tumor metabolism. High-resolution imaging techniques like MRI and PET/CT are fostering breakthroughs in drug discovery, oncology, neurology, and cardiovascular research.

• According to the data, mice accounted for 75.98% of animals used in preclinical research studies, followed by rats at 22.12%. Moreover, emerging markets in the Asia-Pacific region offer untapped growth potential, fueled by increasing investments in the biotechnology and pharmaceutical sectors. These developments present significant opportunities for the small animal imaging market, particularly in areas such as drug development, disease modeling, and preclinical testing across various therapeutic fields.

Technology Insights

The optical imaging segment dominates the market, generating the highest revenue. Its non-invasive nature, high sensitivity, and ability to provide detailed, real-time imaging at a low cost make it indispensable for disease modeling, drug discovery, and therapeutic evaluation. For instance, in October 2024, researchers from Hebrew University introduced image-guided computational holographic wavefront shaping, as reported by the European Research Council. This innovation revolutionizes optical imaging by enabling fast, non-invasive visualization through scattering media, addressing complex imaging challenges effectively.

Request Customizationto receive a tailored report.

Application Insights

The drug discovery and disease modeling segment held the largest market revenue in the global market. Small animals are extensively used to evaluate drug efficacy and study disease mechanisms, particularly in oncology, neurology, and cardiovascular research. These models provide critical in vivo insights into therapeutic effectiveness and safety, accelerating preclinical research. By offering reliable data on drug interactions and disease progression, this segment plays a crucial role in advancing novel treatments and improving the efficiency of drug development pipelines globally.

End-User Insights

Pharmaceutical and biotechnology companies dominate the market, holding the highest market share. These organizations rely on advanced imaging technologies for drug discovery, preclinical testing, and therapeutic evaluations. By using small animal models, they assess drug efficacy, toxicity, and safety before proceeding to human trials. This reliance on small animal imaging enables companies to streamline the drug development process, ensuring more precise and effective treatments while reducing research and development timelines.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America maintains a dominant position in the global market with 40.37% market share, driven by the presence of advanced research facilities, a robust biotechnology and pharmaceutical industry, and significant investments in healthcare innovation. The region hosts numerous academic institutions, private research organizations, and companies actively engaged in drug discovery, disease modeling, and preclinical studies, fueling the demand for cutting-edge imaging technologies. Moreover, strong regulatory support and high adoption rates of innovative imaging solutions bolster North America’s leadership in the market.

• U.S.- The U.S. is a leader in the small animal imaging industry due to its advanced biotechnology infrastructure, high levels of investment in research and development, and mergers and acquisitions of leading small animal imaging companies. For instance, in November 2024, Radon Medical Imaging acquired Alpha Imaging, a major distributor and servicer of medical imaging equipment in the U.S., strengthening its service capabilities and expanding its market reach.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Small Animal Imaging Market Trends

Asia-Pacific is projected to witness the fastest CAGR, attributed to increasing investments in both the technology and pharmaceutical industries. A growing emphasis on preclinical research, coupled with expanding clinical trials and drug development activities in countries like China, Japan, and India, is driving demand for advanced imaging technologies. This rapid growth is further supported by government initiatives and collaborations aimed at enhancing healthcare infrastructure and fostering innovation in small animal imaging.

• India– India is experiencing rapid growth in the market, fueled by government funding and the establishment of new research facilities. In July 2024, India inaugurated Asia's first Pre-clinical Network Facility under the Coalition for Epidemic Preparedness Innovations (CEPI) at the Regional Centre of Biotechnology, Faridabad. This facility advances preclinical research, supporting small animal imaging by enhancing disease modeling, drug testing, and vaccine development.
• China- China’s market for small animal imaging is expanding quickly, driven by significant investments in biomedical research and advancements in imaging technologies. The growing focus on drug discovery and development, combined with government support for research initiatives, continues to foster a strong environment for global market growth. This combination of private and public sector investments positions China as a key player in the global market.
• Japan- Japan is seeing significant growth in its market, driven by advancements in imaging technologies and government support for biomedical research. The country’s increasing focus on preclinical research, particularly in drug discovery and disease modeling, further fuels demand for small animal imaging. Japan’s well-established research infrastructure and growing biotech sector continue to propel the market’s expansion.
• Singapore- The Singapore market for small animal imaging is driven by collaboration between contract research organizations and research institutions for preclinical small animal studies. In May 2024, Ora, Inc., a leading CRO, partnered with the Singapore Eye Research Institute (SERI) to advance ophthalmic research and preclinical studies. SERI, a leader in non-clinical ophthalmic animal studies, specializes in translatable ocular models in small animal species to evaluate therapies for ocular diseases.

Europe Small Animal Imaging Market Trends

• Germany- Germany stands as one of the largest markets for small animal imaging in Europe, driven by strong collaborations between biotechnology companies and healthcare institutions for extensive research studies. In October 2024, GE HealthCare partnered with the University Medicine Essen to establish a theranostics center of excellence. Equipped with cutting-edge technologies, the center aims to advance personalized cancer care research and clinical practice, further propelling the growth of theranostic and personalized medicine in oncology.
• UK- The UK market for small animal imaging is progressing steadily, supported by a strong emphasis on preclinical research, government funding for biomedical research, and advancements in imaging technologies. The country’s leading academic and research institutions play a pivotal role in driving market growth, with many institutions conducting cutting-edge research in disease modeling, drug discovery, and imaging technology development.

Company Market Share

Key players in the small animal imaging industry are actively focusing on adopting a range of strategic business initiatives to strengthen their position in the market. These strategies include strategic collaborations, where companies partner with academic institutions, pharmaceutical firms, and contract research organizations (CROs) to accelerate innovation and expand their research capabilities. Product approvals from regulatory bodies, such as the FDA and CE Mark certifications, are crucial for ensuring market entry and growth in new regions.

Milabs B.v.: An Emerging Player in the Global Small Animal Imaging Market

MILabs B.V. is a leading provider of innovative imaging solutions specializing in small animal imaging systems. The company develops advanced technologies for molecular imaging, offering tools for preclinical research in oncology, neurology, and drug development. MILabs focuses on providing high-resolution imaging systems that combine PET, SPECT, CT, and MRI for comprehensive, non-invasive studies.

Recent developments by MILabs B.V.:

• In March 2024, MILabs partnered with Mid-Atlantic Imaging Services to offer installation and support for its imaging systems in the US and Canada. This agreement enhances access to MILabs' small animal imaging technologies, supporting research in drug discovery and disease modeling.

List of Key and Emerging Players in Small Animal Imaging Market